STAR.NS

Strides Pharma Science Limited · Healthcare · Drug Manufacturers-Specialty & Generic

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$32.45B

PE Ratio

-16.322090347462076

EV to Ebitda

—

Earnings Yield

-506859123.65%

Revenue (TTM)

$431.3M

Net Income (TTM)

$-19.8M

Revenue (Annual YoY Growth)

—

Revenue (Quarterly YoY Growth)

8.90%

Profit Margin

-4.59%

Return on Equity

—

Debt to Equity Ratio

—

Dividend Yield

0.00%

All fundamentals

Core6 fields›

Market Cap$32.45B

Revenue TTM$431.3M

Shares Outstanding90.3M

Float62820613

Insider Ownership34.10%

Institutional Ownership27.20%

Growth Estimates5 fields›

Revenue Growth (Quarterly YoY)8.90%

Rev Growth Est 1Y Forward0.1180

EPS Growth (Quarterly YoY)-36.80%

EPS Growth Est Quarterly0

LT EPS Growth Estimates204.00%

Operations14 fields›

Revenue TTM$431.3M

Gross Margin TTM40.82%

Gross Margin (Quarterly)57.51%

Operating Margin TTM2.51%

Operating Margin (Quarterly)6.49%

Profit Margin TTM-4.59%

Profit Margin (Quarterly)-9.25%

Net Income TTM$-19.8M

EPS TTM-51.28

EBIT Margin TTM8.24%

EBITDA TTM$35.5M

Capex % of Revenue TTM0.00%

Capital Expenditures$0.00M

FCF % of Revenue (Quarterly)-11.24%

Efficiency1 fields›

ROA-0.51%

Valuation6 fields›

P/E (TTM)-16.322090347462076

P/E Forward0

EV/Revenues (TTM)1.621

Earnings Yield-506859123.65%

Dividend Yield0.00%

Payout Ratio0.00%

Liquidity5 fields›

Cash Per Share86.82255972654282

Current Ratio0.9853901675863029

Total Assets$68448.57T

Shareholders Equity$23313.70T

Interest Expense$2.30B

Yields3 fields›

Dividend Yield0.00%

Payout Ratio0.00%

Earnings Yield-506859123.65%